Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
Canopy Growth reported a 22% increase in net revenue to $81.4M for Q2 FY2027, with cannabis segment revenue up 30%. International markets saw a 141% revenue growth, driven by Europe. The company expects to reach positive adjusted EBITDA in FY2027, with ongoing cost savings and international expansion.
How this was made

The 30-second read
Why it matters
The earnings release provides fresh data on revenue growth, margin trends, and progress toward profitability, which can affect investor positioning in the cannabis sector.
Market read
First‑time earnings numbers for a major cannabis player, indicating strong international growth and a path to positive EBITDA, likely to move the stock and sector.
What to watch
The impact of reduced Canadian veterans' reimbursement and inventory step‑up charges could limit near‑term profitability.
Background
Canopy Growth is a leading Canadian cannabis producer listed on both TSX (WEED) and Nasdaq (CGC). The company is pursuing international expansion, particularly in Europe and the UK.
Ticker impact
Canopy Growth reported Q2 FY2027 results with 22% revenue growth and progress toward positive adjusted EBITDA.
potential upside as market prices in strong international revenue growth and path to profitability
The press release provides first‑time earnings numbers showing double‑digit revenue growth and an improving adjusted EBITDA loss, which are new material facts for investors.
Market effects
Highlights growth in the cannabis sector, especially international medical markets.
Boosts sentiment for Canadian and European cannabis stocks.
Signals expanding demand for medical cannabis globally, may influence related biotech and consumer discretionary themes.
Counterpoint
Despite revenue growth, the company still reports a net loss and margin compression, suggesting caution.
Key entities
- CompanyCanopy Growth Corporation
Cannabis producer reporting Q2 FY2027 results.
- CompanyMTL Cannabis Corp.
Acquired entity contributing to revenue growth.


